Page 8 - Successful Listing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Successful listing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Successful Listing Today - Breaking & Trending Today

GT Biopharma Reports Fourth Quarter and Year End 2020 Results and Business Update


Published: Apr 19, 2021
 
BEVERLY HILLS, Calif., April 19, 2021 /PRNewswire/  GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company s proprietary natural killer (NK) cell engager (TriKE™) protein biologic technology platform, reported financial results for the fourth quarter and year ended December 31, 2020.
2020 was a year of robust clinical progress and milestone achievements for GT Biopharma, which allowed us to accomplish a major corporate milestone in listing GT Biopharma on NASDAQ at the beginning of 2021.  The emerging data from our GTB-3550 TriKE™ program in hematological malignancies, MDS and AML, are encouraging in both safety and efficacy profiles.  The ongoing data profile has demonstrated significant differences from all other NK cell therapies and NK engager companies, making TriKE™ a monotherapy, off-the-shelf platform therapeutic.  TriKE™ exerts ....

United States , Samir Taneja , Julie Seidel , Cytovance Biologics , Michael Handelman , Philip Werthman , Rajesh Shrotriya , Greg Berk , Susan Roush , Jeffreys Miller , Anthonyj Cataldo , David Castaneda , Beverly Hills , Michael Breen , Brucej Wendel , Iovance Biotherapeutics , Hospital Harvard Medical School , Company Scientific , Stern Investor Relations Inc , Source Gt Biopharma Inc , Exchange Commission , American Society Of Hematology , Development Expenses , University Of Wisconsin , Leadership Team , University Of Minnesota ,